Cost Effectiveness of Nivolumab for Patients with Advanced, Previously Treated Renal Cell Carcinoma in Scotland
Abstract
Authors
S Mahon A Bullement A Willis W Sullivan JA Britton L Cox D Tyas A Sowdani
S Mahon A Bullement A Willis W Sullivan JA Britton L Cox D Tyas A Sowdani
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now